Besides, lymphocyte activation gene-3 (LAG-3) knockout CD19-specific CAR-T cells by CRISPR-Cas9 elicited strong antigen-specific anti-tumor effects in vitro and lymphoma Raji cell-bearing NOD-Prkdcscid Il2rgnull (NPG) mice. Here, LAG3 is linked to neoplasm.